CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Bloop Hemorrhoid Relief Topical

14.4% Glycerin, 0.25% Phenylephrine HCL, 1% Pramoxine HCL, 15% Petrolatum· ingredient pramoxineAdrenergic and dopaminergic agents· GLYCERIN 14.4 g/100g; PETROLATUM 15 g/100g; GLYCERIN 14.4 g/100g; PHENYLEPHRINE HYDROCHLORIDE .25 g/100g; GLYCERIN 144 mg/g; PETROLATUM 150 mg/g; GLYCERIN 144 mg/g; PHENYLEPHRINE HYDROCHLORIDE 2.5 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.06318
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other pramoxine products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

ProductNADAC / GMvs this
Calaclear$0.01361−$0.04960
antibiotic$0.09664+$0.03350
hydrocortisone acetate pramoxine HCl$1.75+$1.69
Analpram HC$3.11+$3.05

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.